BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 29395338)

  • 21. The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.
    Sallée M; Dou L; Cerini C; Poitevin S; Brunet P; Burtey S
    Toxins (Basel); 2014 Mar; 6(3):934-49. PubMed ID: 24599232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a Sensitive Human Immunological Target of Aryl Hydrocarbon Receptor Activation: CD5
    Blevins LK; Zhou J; Crawford RB; Kaminski NE
    Front Immunol; 2021; 12():635748. PubMed ID: 33936048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the transcriptional regulation and molecular function of the aryl hydrocarbon receptor repressor in human cell lines.
    Haarmann-Stemmann T; Bothe H; Kohli A; Sydlik U; Abel J; Fritsche E
    Drug Metab Dispos; 2007 Dec; 35(12):2262-9. PubMed ID: 17890447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tryptophan metabolites suppress the Wnt pathway and promote adverse limb events in chronic kidney disease.
    Arinze NV; Yin W; Lotfollahzadeh S; Napoleon MA; Richards S; Walker JA; Belghasem M; Ravid JD; Hassan Kamel M; Whelan SA; Lee N; Siracuse JJ; Anderson S; Farber A; Sherr D; Francis J; Hamburg NM; Rahimi N; Chitalia VC
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34752422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling.
    MacPherson L; Ahmed S; Tamblyn L; Krutmann J; Förster I; Weighardt H; Matthews J
    Int J Mol Sci; 2014 May; 15(5):7939-57. PubMed ID: 24806346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dioxin induces Ahr-dependent robust DNA demethylation of the Cyp1a1 promoter via Tdg in the mouse liver.
    Amenya HZ; Tohyama C; Ohsako S
    Sci Rep; 2016 Oct; 6():34989. PubMed ID: 27713569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal and tissue-specific activation of aryl hydrocarbon receptor in discrete mouse models of kidney disease.
    Walker JA; Richards S; Belghasem ME; Arinze N; Yoo SB; Tashjian JY; Whelan SA; Lee N; Kolachalama VB; Francis J; Ravid K; Sherr D; Chitalia VC
    Kidney Int; 2020 Mar; 97(3):538-550. PubMed ID: 31932072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice.
    Harrill JA; Hukkanen RR; Lawson M; Martin G; Gilger B; Soldatow V; Lecluyse EL; Budinsky RA; Rowlands JC; Thomas RS
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):503-18. PubMed ID: 23859880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aryl Hydrocarbon Receptor Ablation in Cardiomyocytes Protects Male Mice From Heart Dysfunction Induced by NKX2.5 Haploinsufficiency.
    Wang Q; Fan Y; Kurita H; Jiang M; Koch S; Rao MB; Rubinstein J; Puga A
    Toxicol Sci; 2017 Nov; 160(1):74-82. PubMed ID: 28973413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astrocytic aryl hydrocarbon receptor mediates chronic kidney disease-associated mental disorders involving GLT1 hypofunction and neuronal activity enhancement in the mouse brain.
    Huang YJ; Hung CC; Hsu PC; Lee PY; Tsai YA; Hsin YC; Lee XT; Chou CC; Chen ML; Tarng DC; Lee YH
    Glia; 2023 Apr; 71(4):1057-1080. PubMed ID: 36573349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic Overexpression of Aryl Hydrocarbon Receptor Repressor (AhRR) and AhR-Mediated Induction of CYP1A1, Cytokines, and Acute Toxicity.
    Vogel CF; Chang WL; Kado S; McCulloh K; Vogel H; Wu D; Haarmann-Stemmann T; Yang G; Leung PS; Matsumura F; Gershwin ME
    Environ Health Perspect; 2016 Jul; 124(7):1071-83. PubMed ID: 26862745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-Methyl-D-tryptophan activates aryl hydrocarbon receptor, a pathway associated with bladder cancer progression.
    Matheus LHG; Dalmazzo SV; Brito RBO; Pereira LA; de Almeida RJ; Camacho CP; Dellê H
    BMC Cancer; 2020 Sep; 20(1):869. PubMed ID: 32907554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aryl Hydrocarbon Receptor Inhibition Restores Indoxyl Sulfate-Mediated Endothelial Dysfunction in Rat Aortic Rings.
    Nguyen C; Edgley AJ; Kelly DJ; Kompa AR
    Toxins (Basel); 2022 Jan; 14(2):. PubMed ID: 35202128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor.
    Schroeder JC; Dinatale BC; Murray IA; Flaveny CA; Liu Q; Laurenzana EM; Lin JM; Strom SC; Omiecinski CJ; Amin S; Perdew GH
    Biochemistry; 2010 Jan; 49(2):393-400. PubMed ID: 20000589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concentration and Duration of Indoxyl Sulfate Exposure Affects Osteoclastogenesis by Regulating NFATc1 via Aryl Hydrocarbon Receptor.
    Liu WC; Shyu JF; Lim PS; Fang TC; Lu CL; Zheng CM; Hou YC; Wu CC; Lin YF; Lu KC
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate.
    Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M
    Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indoxyl Sulfate Upregulates Liver P-Glycoprotein Expression and Activity through Aryl Hydrocarbon Receptor Signaling.
    Santana Machado T; Poitevin S; Paul P; McKay N; Jourde-Chiche N; Legris T; Mouly-Bandini A; Dignat-George F; Brunet P; Masereeuw R; Burtey S; Cerini C
    J Am Soc Nephrol; 2018 Mar; 29(3):906-918. PubMed ID: 29222397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leflunomide induces NAD(P)H quinone dehydrogenase 1 enzyme via the aryl hydrocarbon receptor in neonatal mice.
    Shrestha AK; Patel A; Menon RT; Jiang W; Wang L; Moorthy B; Shivanna B
    Biochem Biophys Res Commun; 2017 Mar; 485(1):195-200. PubMed ID: 28192119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Editor's Highlight: Ah Receptor Activation Potentiates Neutrophil Chemoattractant (C-X-C Motif) Ligand 5 Expression in Keratinocytes and Skin.
    Smith KJ; Boyer JA; Muku GE; Murray IA; Gowda K; Desai D; Amin SG; Glick AB; Perdew GH
    Toxicol Sci; 2017 Nov; 160(1):83-94. PubMed ID: 28973351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aryl hydrocarbon receptor repressor (AhRR) function revisited: repression of CYP1 activity in human skin fibroblasts is not related to AhRR expression.
    Tigges J; Weighardt H; Wolff S; Götz C; Förster I; Kohne Z; Huebenthal U; Merk HF; Abel J; Haarmann-Stemmann T; Krutmann J; Fritsche E
    J Invest Dermatol; 2013 Jan; 133(1):87-96. PubMed ID: 22951721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.